NCT04477512 2025-11-12
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
Washington University School of Medicine
Phase 1 Completed
Washington University School of Medicine
Weill Medical College of Cornell University
National University Hospital, Singapore
Stanford University
Dana-Farber Cancer Institute
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Radboud University Medical Center